NCT06698250 Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA) Status RECRUITING Phase PHASE2
NCT06694636 Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT06679985 A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06669377 TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT. Status RECRUITING Phase N/A
NCT06658782 Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer Status RECRUITING Phase N/A
NCT06645314 Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06632717 Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT06626087 A Prototype AI Algorithm Versus Liver Imaging Reporting and Data System (LI-RADS) Criteria in Diagnosing HCC on CT Status COMPLETED Phase NA
NCT06624189 Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis Status ENROLLING_BY_INVITATION Phase N/A
NCT06623474 Correlation Study of Lipid Metabolites as Markers of Hepatocellular Carcinoma Status RECRUITING Phase N/A
NCT06622031 TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT Status RECRUITING Phase NA
NCT06620510 Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea Status COMPLETED Phase N/A
NCT06617000 A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related Status RECRUITING Phase PHASE1
NCT06609876 Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC Status RECRUITING Phase NA
NCT06607120 Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies Status RECRUITING Phase N/A
NCT06602011 Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002) Status RECRUITING Phase N/A
NCT06592612 Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment Status NOT_YET_RECRUITING Phase PHASE2
NCT06590246 A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC) Status RECRUITING Phase PHASE1/PHASE2